Granted Patent
Utility
US 6,670,335
· Confirmation No. 3400
FLUOROURACIL-CONTAINING FORMULATION
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2016-08-29 | SOL.NTC.SUIT |
Report on the filing or determination of an action regarding a patent | 1 | View | |
| 2013-09-24 | N570 |
Communication - Re: Power of Attorney (PTOL-308) | 1 | View | |
| 2013-09-24 | N570 |
Communication - Re: Power of Attorney (PTOL-308) | 1 | View | |
| 2013-09-11 | PA.. |
Power of Attorney | 1 | View | |
| 2013-09-11 | R3.73 |
Assignee showing of ownership per 37 CFR 3.73 | 1 | View | |
| 2013-09-11 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2012-05-07 | SOL.NTC.SUIT |
Report on the filing or determination of an action regarding a patent | 1 | View | |
| 2012-05-03 | SOL.NTC.SUIT |
Report on the filing or determination of an action regarding a patent | 1 | View | |
| 2009-08-13 | N570 |
Communication - Re: Power of Attorney (PTOL-308) | 1 | View | |
| 2009-08-13 | N570 |
Communication - Re: Power of Attorney (PTOL-308) | 1 | View | |
| 2009-08-07 | PA.. |
Power of Attorney | 1 | View | |
| 2009-08-07 | R3.73 |
Assignee showing of ownership per 37 CFR 3.73 | 1 | View | |
| 2009-08-07 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2008-09-18 | N570 |
Communication - Re: Power of Attorney (PTOL-308) | 1 | View | |
| 2008-09-18 | N570 |
Communication - Re: Power of Attorney (PTOL-308) | 1 | View | |
| 2008-09-09 | PA.. |
Power of Attorney | 1 | View | |
| 2008-09-09 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2008-09-09 | R3.73 |
Assignee showing of ownership per 37 CFR 3.73 | 1 | View | |
| 2003-10-20 | PA.. |
Power of Attorney | 3 | View | |
| 2003-10-14 | IFEE |
Issue Fee Payment (PTO-85B) | 2 | View | |
| 2003-10-14 | C.AD |
Change of Address | 1 | View | |
| 2001-03-05 | TRNA |
Transmittal of New Application | 2 | View | |
| 2001-03-05 | SPEC |
Specification | 12 | View | |
| 2001-03-05 | CLM |
Claims | 2 | View | |
| 2001-03-05 | ABST |
Abstract | 1 | View | |
| 2001-03-05 | OATH |
Oath or Declaration filed | 3 | View |
Inventors
B. Sandhya Singh
San Jose, CA
Subhash J. Saxena
Belmont, CA
Attorneys & Agents of Record
Classification
USPC
514/50
A61K8/06
A61K8/0279
A61K8/062
A61K8/4926
A61K2800/56
A61Q19/00
A61Q19/004
Prosecution
- Examiner
- FAY, ZOHREH ALEMZADEH
- Art Unit
- 1614
- Customer No.
- 108547
- Confirmation No.
- 3400
Publication
- Pub. No.
- US20020165198A1
- Pub. Date
- 2002-11-07
Patent Term Adjustment
-15days
No related applications found.
BAUSCH HEALTH IRELAND LIMITED,
BAUSCH HEALTH COMPANIES INC.,
BAUSCH HEALTH, CANADA INC.,
TECHNOLAS PERFECT VISION GMBH,
VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.,
VALEANT PHARMA POLAND SPOLKA Z ORGANICZONA ODPOWIEDZIALNOSCIA,
VALEANT SP. Z.O.O.
RELEASE OF SECURITY INTEREST
Recorded 2025-11-20
SOLTA MEDICAL, INC.,
PRECISION DERMATOLOGY, INC.,
BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED),
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD,
SANTARUS, INC.,
MEDICIS PHARMACEUTICAL CORPORATION,
HUMAX PHARMACEUTICAL S.A.,
SOLTA MEDICAL IRELAND LIMITED,
BAUSCH & LOMB MEXICO, S.A. DE C.V.,
BAUSCH+LOMB OPS B.V.,
BAUSCH HEALTH AMERICAS, INC.,
BAUSCH HEALTH COMPANIES INC.,
BAUSCH HEALTH HOLDCO LIMITED,
BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC),
BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA),
BAUSCH HEALTH US, LLC,
BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.,
ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.),
ORAPHARMA, INC.,
PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.),
SOLTA MEDICAL DUTCH HOLDINGS B.V.,
V-BAC HOLDING CORP.,
VRX HOLDCO LLC,
1261229 B.C. LTD.,
1530065 B.C. LTD.
RELEASE OF SECURITY INTEREST
Recorded 2025-04-08
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2019-10-24
from
BAUSCH HEALTH COMPANIES INC.,
BAUSCH HEALTH IRELAND LIMITED,
BAUSCH HEALTH, CANADA INC.,
TECHNOLAS PERFECT VISION GMBH,
VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA,
VALEANT PHARMACEUTICALS LUXEMBOURG S.À R.L.,
VALEANT SP. Z O. O.
INTELLECTUAL PROPERTY SECURITY AGREEMENT
Recorded 2019-07-03
from
BAUSCH & LOMB INCORPORATED,
DOW PHARMACEUTICAL SCIENCES, INC.,
MEDICIS PHARMACEUTICAL CORPORATION,
SALIX PHARMACEUTICALS, LTD,
SOLTA MEDICAL, INC.,
TECHNOLAS PERFECT VISION GMBH,
VALEANT PHARMACEUTICALS LUXEMBOURG S.A.R.L.,
VALEANT PHARMACEUTICALS NORTH AMERICA
SECURITY INTEREST
Recorded 2018-08-10
from
BAUSCH & LOMB INCORPORATED,
DOW PHARMACEUTICAL SCIENCES, INC.,
MEDICIS PHARMACEUTICAL CORPORATION,
SALIX PHARMACEUTICALS, LTD,
SOLTA MEDICAL, INC.,
TECHNOLAS PERFECT VISION GMBH,
VALEANT PHARMACEUTICALS LUXEMBOURG S.A.R.L.,
VALEANT PHARMACEUTICALS NORTH AMERICA
SECURITY INTEREST
Recorded 2018-08-10
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2016-07-19
RELEASE OF SECURITY INTEREST
Recorded 2014-10-20
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE'S NAME FROM A.P. PARMA, INC. TO A.P. PHARMA, INC. PREVIOUSLY RECORDED ON REEL 026926 FRAME 0385. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNEE'S NAME TO READ A.P. PHARMA, INC.
Recorded 2011-09-19
from
A.P. PHARMA, INC.
COLLATERAL ASSIGNMENT AND SECURITY AGREEMENT
Recorded 2006-01-17
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2001-03-05
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- Patent No.
- US 6,670,335
- App. No.
- 09/799,792
- Filed
- 2001-03-05
- Granted
- 2003-12-30
- Pub. No.
- US20020165198A1
- Examiner
- FAY, ZOHREH ALEMZADEH
- Art Unit
- 1614
- PTA
- -15 days
External Links